PT90376A - Processo para a preparacao de peptidos env-codificados de hiv capazes de elicitarem anticorpos que inibem hiv em mamiferos e de anticorpos monoclonais que inibem hiv mediante utilizacao desses peptidos - Google Patents

Processo para a preparacao de peptidos env-codificados de hiv capazes de elicitarem anticorpos que inibem hiv em mamiferos e de anticorpos monoclonais que inibem hiv mediante utilizacao desses peptidos

Info

Publication number
PT90376A
PT90376A PT90376A PT9037689A PT90376A PT 90376 A PT90376 A PT 90376A PT 90376 A PT90376 A PT 90376A PT 9037689 A PT9037689 A PT 9037689A PT 90376 A PT90376 A PT 90376A
Authority
PT
Portugal
Prior art keywords
hiv
peptides
antibodies
codified
env
Prior art date
Application number
PT90376A
Other languages
English (en)
Other versions
PT90376B (pt
Inventor
Stephen Robert Petteway Jr
William Robert Kenealy
Paul John Durda
Original Assignee
Du Pont Merck Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/324,027 external-priority patent/US5562905A/en
Application filed by Du Pont Merck Pharma filed Critical Du Pont Merck Pharma
Publication of PT90376A publication Critical patent/PT90376A/pt
Publication of PT90376B publication Critical patent/PT90376B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • AIDS & HIV (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT90376A 1988-04-26 1989-04-26 Processo para a preparacao de peptidos env-codificados de hiv capazes de elicitarem anticorpos que inibem hiv em mamiferos e de anticorpos monoclonais que inibem hiv mediante utilizacao desses peptidos PT90376B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18633388A 1988-04-26 1988-04-26
US07/324,027 US5562905A (en) 1988-04-26 1989-03-20 Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals

Publications (2)

Publication Number Publication Date
PT90376A true PT90376A (pt) 1989-11-10
PT90376B PT90376B (pt) 1995-01-31

Family

ID=26881983

Family Applications (1)

Application Number Title Priority Date Filing Date
PT90376A PT90376B (pt) 1988-04-26 1989-04-26 Processo para a preparacao de peptidos env-codificados de hiv capazes de elicitarem anticorpos que inibem hiv em mamiferos e de anticorpos monoclonais que inibem hiv mediante utilizacao desses peptidos

Country Status (10)

Country Link
EP (1) EP0339504A3 (pt)
JP (1) JPH02160800A (pt)
AU (1) AU632475B2 (pt)
DK (1) DK200189A (pt)
FI (1) FI891957A (pt)
HU (1) HUT51296A (pt)
IL (1) IL90058A0 (pt)
NO (1) NO891711L (pt)
NZ (1) NZ228869A (pt)
PT (1) PT90376B (pt)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990012868A1 (en) * 1989-04-25 1990-11-01 Tanox Biosystems, Inc. Antibodies specific for cd4-binding domain of hiv
CA2058630A1 (en) * 1989-06-05 1990-12-06 Charles F. Scott, Jr. Human monoclonal antibodies to hiv-1 mn gp 120
SE9000333D0 (sv) * 1990-01-31 1990-01-31 Britta Wahren Monoklonal antikropp
US7041293B1 (en) 1990-04-03 2006-05-09 Genentech, Inc. HIV env antibodies
AU647108B2 (en) * 1990-04-03 1994-03-17 Genentech Inc. Methods and compositions for vaccination against HIV
AU8007991A (en) * 1990-06-29 1992-01-23 Daniel Zagury Methods of inducing immune response to aids virus
US5712373A (en) * 1990-07-02 1998-01-27 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute HIV monoclonal antibody specific for the HTLV-IIImn gp120 envelope glycoprotein
JP2989862B2 (ja) * 1990-07-02 1999-12-13 財団法人化学及血清療法研究所 モノクローナル抗体
IL98845A0 (en) * 1990-07-19 1992-07-15 Merck & Co Inc Coconjugate vaccines comprising immunogenic protein,hiv related peptides,and anionic moieties,their preparation and pharmaceutical compositions containing them
CA2047042A1 (en) * 1990-07-19 1992-01-20 John Hannah Cyclic hiv principal neutralizing determinant peptides
CA2047078A1 (en) * 1990-07-19 1992-01-20 Steven S. Bondy Cyclic hiv principal neutralizing determinant peptides
IL99077A0 (en) * 1990-08-13 1992-07-15 Merck & Co Inc New embodiments of the hiv principal neutralizing determinant and pharmaceutical compositions containing them
US5346989A (en) * 1990-08-22 1994-09-13 Syntello Vaccine Development Kb Peptides for use in induction of T cell activation against HIV-1
US5627035A (en) * 1990-08-22 1997-05-06 Syntello Vaccine Development Ab Peptides that block human immunodeficiency virus and methods of use thereof
WO1992021377A1 (en) * 1991-06-03 1992-12-10 Syntello Inc. Peptides for use in induction of t cell activation against hiv-1
WO1993004090A1 (en) * 1991-08-22 1993-03-04 Nissin Shokuhin Kabushiki Kaisha Hiv immunotherapeutics
WO1994004574A1 (en) * 1991-08-22 1994-03-03 Nissin Shokuhin Kabushiki Kaisha Hiv immunotherapeutics
DK0671947T3 (da) * 1991-12-02 2000-07-24 Univ Texas Præparater til udløsning af cytotoksisk T-lymfocyt-responser mod virus
CA2084180A1 (en) * 1991-12-11 1993-06-12 Paul P. Hung Expression of specific immunogens using viral antigens
JPH0748276A (ja) * 1992-03-26 1995-02-21 Inmeru:Kk Ｈｉｖ感染症予防ワクチンおよびその製造法
WO1993019775A1 (en) * 1992-03-31 1993-10-14 Medimmune, Inc. Administration of liposomes containing peptides or proteins including ctl eptitopes of hiv proteins
AU5359094A (en) * 1992-10-13 1994-05-09 Children's Hospital Oral tolerance and immune suppression in the treatment of aids
US5274122A (en) * 1992-10-15 1993-12-28 Merck & Co., Inc. Acidic derivatives of homocysteine thiolactone
US6114143A (en) * 1993-03-11 2000-09-05 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Anti-HIV monoclonal antibody
US6180134B1 (en) 1993-03-23 2001-01-30 Sequus Pharmaceuticals, Inc. Enhanced ciruclation effector composition and method
EP0708659A4 (en) * 1993-06-07 2000-08-23 Genentech Inc HIV ENVELOPE POLYPEPTIDE
US5939277A (en) * 1993-10-15 1999-08-17 Rakowicz-Szulczynska; Eva M. Detection and treatment of breast and gynecological cancer
US6585979B1 (en) 1996-07-08 2003-07-01 Genentech, Inc. HIV envelope polypeptides and immunogenic composition
ZA975889B (en) * 1996-07-08 1998-02-23 Genentech Inc HIV envelope polypeptides and vaccine.
FR2874612A1 (fr) * 2004-08-27 2006-03-03 Commissariat Energie Atomique Epitotes t cd4+ du vih restreints a hla-dp4 et leurs applications
EP2778681A1 (en) * 2013-03-15 2014-09-17 Biomay Ag Method for diagnosing a viral infection

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2571968B1 (fr) * 1984-10-18 1989-03-17 Pasteur Institut Virus purifie des lymphadenopathies et du syndrome d'immuno-depression acquise et antigenes d'enveloppe de ce virus, procede d'obtention de ce virus et de ces antigenes d'enveloppe de ce virus, applications de ce virus ou de ces antigenes a la preparation de compositions immunogenes ou pour le diagnostic des susdites affections.
NZ230372A (en) * 1984-10-18 1994-02-25 Pasteur Institut Hiv antigen, assay and vaccine.
GB8501473D0 (en) * 1985-01-21 1985-02-20 Pasteur Institut Cloned dna sequences
WO1987002775A1 (en) * 1985-10-24 1987-05-07 Southwest Foundation For Biomedical Research Synthetic peptides and use for diagnosis and vaccination for aids and arc
JPH01501547A (ja) * 1986-06-12 1989-06-01 バイオジェン　ナームローズ　ベンノットシャップ Ｈｉｖ感染の病因に関するペプチド
NZ221440A (en) * 1986-08-20 1991-11-26 Genetic Systems Corp Composition containing monoclonal antibodies/peptides useful in treating and diagnosing hiv infections
ATE122237T1 (de) * 1987-05-29 1995-05-15 Tanox Biosystems Inc Hiv-1 neutralisierende monoklonale antikörper.
EP0400076B1 (en) * 1988-01-26 1996-05-15 THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce A synthetic antigen evoking anti-hiv response

Also Published As

Publication number Publication date
DK200189A (da) 1989-10-27
NZ228869A (en) 1992-02-25
NO891711D0 (no) 1989-04-25
JPH02160800A (ja) 1990-06-20
DK200189D0 (da) 1989-04-25
EP0339504A3 (en) 1990-09-12
IL90058A0 (en) 1989-12-15
EP0339504A2 (en) 1989-11-02
PT90376B (pt) 1995-01-31
FI891957A (fi) 1989-10-27
HUT51296A (en) 1990-04-28
FI891957A0 (fi) 1989-04-25
AU3332089A (en) 1989-11-02
NO891711L (no) 1989-10-27
AU632475B2 (en) 1993-01-07

Similar Documents

Publication Publication Date Title
PT90376A (pt) Processo para a preparacao de peptidos env-codificados de hiv capazes de elicitarem anticorpos que inibem hiv em mamiferos e de anticorpos monoclonais que inibem hiv mediante utilizacao desses peptidos
BR8403498A (pt) Processo para a preparacao de corpos de moldacao reforcados repelentes as chamas de poliesteres,corpos de moldacao e massas de moldacao
BR8903537A (pt) Processo para a preparacao de sulfonatos de olefinas internas,e,sulfonatos de olefinas internas
BR8903014A (pt) Polimero reforcado e processo para sua preparacao
BR8602636A (pt) Composito resistente ao impacto e processo para sua preparacao
DE3681977D1 (de) Durch hybridfasern verstaerkter verbundwerkstoff.
EP0415920A4 (en) Monoclonal antibody specific to hiv antigens
ES528001A0 (es) Un procedimiento para fraccionar anticuerpos de suero.
BR8304561A (pt) Poliisoftalato ou um seu copolimero e processo para sua preparacao
PT90293A (pt) Processo para a preparacao de macrolidos
IT1222518B (it) Anticorpi monoclonali e peptidi utili a trattare e diagnosticare infezione da hiv
PT92325A (pt) Processo para a preparacao de polieter-poliois com insaturacao reduzida
BR8306412A (pt) Folha composta termomoldavel e processo para sua preparacao
BR8906327A (pt) Processo para a preparacao de organoclorossilanos
PT90323A (pt) Processo para a preparacao de anticorpos monoclonais
PT92638A (pt) Processo para a preparacao de poliazamacrociclos mono-n-alquilados
BR7801659A (pt) Produto composito e processo para a sua preparacao
BR8303196A (pt) Processo para preparacao de um catalisador de dhidrocraquear e catalisador assim obtido
BR8405553A (pt) Processo para a fabricacao de objetos compositos
KR890700683A (ko) 인체 면역 결핍 바이러스에 대한 항체 검색 방법
BR8903367A (pt) Processo para a preparacao de organoclorossilanos
BR7908461A (pt) Laminado metal-termoplastico-metal e processo para a preparacao de um laminado metal-termoplastic-metal
BR7601066A (pt) Processo de uniao para travar rigidamente uma primeira peca a uma segunda peca;dispositivo com ranhura;porca;e dispositivo de uniao
BR8804094A (pt) Processo para a preparacao de gelatinas e gelatinas obtidas
PT92507A (pt) Processo para a preparacao de alfa-ciano-beta-oxopropionamidas

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19940719

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19960131